Targeting gliovascular connexins prevents inflammatory blood-brain barrier leakage and astrogliosis
Authors:
- Marijke De BockMBMarijke De Bock
- Stijn VerwaerdeSVStijn Verwaerde
- Hanane TahiriHTHanane Tahiri
- Steffi SchumacherSSSteffi Schumacher
- Valérie Van HaverVHValérie Van Haver
- Katja WitschasKWKatja Witschas
- Christian SteinhäuserCSChristian Steinhäuser
- Nathalie RouachNRNathalie Rouach
- Roosmarijn E. VandenbrouckeRoosmarijn E. Vandenbroucke
- Luc LeybaertLLLuc Leybaert
Open Access
- 22 August 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (16)
Abstract
The blood-brain barrier is formed by capillary endothelial cells expressing connexin 37 (Cx37), Cx40, and Cx43 and is joined by closely apposed astrocytes expressing Cx43 and Cx30. We investigated whether connexin-targeting peptides could limit barrier leakage triggered by LPS-induced systemic inflammation in mice. Intraperitoneal LPS administration increased endothelial and astrocytic Cx43 expression; elevated TNF-α, IL-1β, IFN-γ, and IL-6 in plasma and IL-6 in the brain; and induced barrier leakage recorded over 24 hours. Barrier leakage was largely prevented by global Cx43 knockdown and Cx43/Cx30 double knockout in astrocytes, slightly diminished by endothelial Cx43 knockout, and not protected by global Cx30 knockout. Intravenous administration of Gap27 or Tat-Gap19 peptides just before LPS also prevented barrier leakage, and intravenously administered BAPTA-AM to chelate intracellular calcium was equally effective. Patch-clamp experiments demonstrated LPS-induced Cx43 hemichannel opening in endothelial cells, which was suppressed by Gap27, Gap19, and BAPTA. LPS additionally triggered astrogliosis that was prevented by intravenous Tat-Gap19 or BAPTA-AM. Cortically applied Tat-Gap19 or BAPTA-AM to primarily target astrocytes also strongly diminished barrier leakage. In vivo dye uptake and in vitro patch-clamp showed Cx43 hemichannel opening in astrocytes that was induced by IL-6 in a calcium-dependent manner. We conclude that targeting endothelial and astrocytic connexins is a powerful approach to limit barrier failure and astrogliosis.Keywords
Funding Information
- Fund for Scientific Research Flanders, Belgium (G.0A82.13N G.0320.15N G052718N)
- Geneeskundige Stichting Koningin Elisabeth, Belgium (STI.DI2.2017.0004.01)
This publication has 91 references indexed in Scilit:
- Systemic Immune Activation Leads to Neuroinflammation and Sickness Behavior in MiceMediators of Inflammation, 2013
- Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injuryBasic Research in Cardiology, 2012
- Connexin mimetic peptides inhibit Cx43 hemichannel opening triggered by voltage and intracellular Ca2+ elevationBasic Research in Cardiology, 2012
- Connexin 43 Hemichannels Contribute to Cytoplasmic Ca2+ Oscillations by Providing a Bimodal Ca2+-dependent Ca2+ Entry PathwayJournal of Biological Chemistry, 2012
- In Vivo Imaging of Ca2+ Signaling in Astrocytes Using Two-Photon Laser Scanning Fluorescent Microscopy2011
- Lipopolysaccharide modulates astrocytic S100B secretion: a study in cerebrospinal fluid and astrocyte cultures from ratsJournal of Neuroinflammation, 2011
- Connexin Channels Provide a Target to Manipulate Brain Endothelial Calcium Dynamics and Blood—Brain Barrier PermeabilityJournal of Cerebral Blood Flow & Metabolism, 2011
- Minimal penetration of lipopolysaccharide across the murine blood–brain barrierBrain, Behavior, and Immunity, 2010
- Gap Junctions in the Control of Vascular FunctionAntioxidants & Redox Signaling, 2009
- Sulforhodamine 101 as a specific marker of astroglia in the neocortex in vivoNature Methods, 2004